search
Back to results

Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years

Primary Purpose

Lung Cancer, Tobacco Use Disorder

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
caregiver-related intervention or procedure
questionnaire administration
quality-of-life assessment
radiography
Sponsored by
Wales Cancer Trials Unit
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Lung Cancer focused on measuring non-small cell lung cancer, small cell lung cancer, tobacco use disorder

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

DISEASE CHARACTERISTICS:

  • Patients over 60 seeing a participating General Practitioner
  • Currently smokes 10 or more pack years, meeting at least one of the following criteria:

    • New or altered cough of any duration reported to primary care
    • Increased breathlessness or wheezing (with or without purulent sputum)
  • Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following:

    • Cough
    • Chest/shoulder pain
    • Dyspnea
    • Weight loss
    • Chest signs
    • Hoarseness
    • Finger clubbing
    • Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin)
    • Cervical/supraclavicular lymphadenopathy

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • No chest x-ray within in past 3 months
  • No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Prevalence of extra-NICE symptoms in patients consulting in UK general practice
    Proportion of patients who agree to participate in the trial
    Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers

    Secondary Outcome Measures

    Best way to train general practitioners to identify and recruit eligible patients into the trial
    Most effective method of presenting the trial (and randomization) to patients
    Barriers to recruitment and how to overcome those barriers
    Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
    Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
    Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
    False-positive and false-negative rates for chest x-rays

    Full Information

    First Posted
    April 27, 2011
    Last Updated
    August 23, 2013
    Sponsor
    Wales Cancer Trials Unit
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01344005
    Brief Title
    Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years
    Official Title
    A Pilot Clinical Trial Looking at the Effect on Lung Cancer Diagnosis of Giving a CXR to Smokers Aged Over 60 With Chest Symptoms
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2011
    Overall Recruitment Status
    Unknown status
    Study Start Date
    June 2011 (undefined)
    Primary Completion Date
    June 2013 (Anticipated)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Wales Cancer Trials Unit

    4. Oversight

    5. Study Description

    Brief Summary
    RATIONALE: Diagnostic procedures, such as an urgent chest x-ray, may help in planning cancer treatment. It is not yet known whether standard medical care is more effective than an urgent x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years. PURPOSE: This randomized clinical trial is studying standard medical care to see how well it works compared with an urgent chest x-ray in diagnosing lung cancer in smokers with chest symptoms who are older than 60 years.
    Detailed Description
    OBJECTIVES: Primary To determine the prevalence of extra-NICE symptoms in patients consulting in UK general practice. To determine the proportion of patients who agree to participate in the trial. To determine the proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers. Secondary To determine the best way to train general practitioners to identify and recruit eligible patients into the trial. To determine the most effective method of presenting the trial (and randomization) to patients. To determine the barriers to recruitment and how to overcome those barriers. To determine the best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays. To determine the best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'. To determine the stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer. OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 treatment arms. Arm A: Patients are managed as per the National Institute for Health and Clinical Excellence (NICE) guidelines. Arm B: Patients are referred for an urgent chest x-ray according to extra-NICE guidelines. General practitioners from South East Wales are surveyed to assess their level of interest in the proposed full trial. For the feasibility study, 20 South East Wales general practices and 6 South Yorkshire general practices are selected. General practitioners are trained to recruit all patients who fulfill the extra-NICE criteria as well as those who do not. Patients complete questionnaires (HADS, EQ-5D, and ICECAP[O]) at baseline and at 2 months to measure quality of life and health economic analysis of the cost-effectiveness of extra-NICE guidelines. Peer Reviewed and Funded or Endorsed by Cancer Research UK.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Lung Cancer, Tobacco Use Disorder
    Keywords
    non-small cell lung cancer, small cell lung cancer, tobacco use disorder

    7. Study Design

    Primary Purpose
    Diagnostic
    Study Phase
    Not Applicable
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    386 (Anticipated)

    8. Arms, Groups, and Interventions

    Intervention Type
    Other
    Intervention Name(s)
    caregiver-related intervention or procedure
    Intervention Type
    Other
    Intervention Name(s)
    questionnaire administration
    Intervention Type
    Procedure
    Intervention Name(s)
    quality-of-life assessment
    Intervention Type
    Procedure
    Intervention Name(s)
    radiography
    Primary Outcome Measure Information:
    Title
    Prevalence of extra-NICE symptoms in patients consulting in UK general practice
    Title
    Proportion of patients who agree to participate in the trial
    Title
    Proportion of patients who are diagnosed with lung cancer and the best sources of routine data for capturing lung cancers
    Secondary Outcome Measure Information:
    Title
    Best way to train general practitioners to identify and recruit eligible patients into the trial
    Title
    Most effective method of presenting the trial (and randomization) to patients
    Title
    Barriers to recruitment and how to overcome those barriers
    Title
    Best tools to use to measure anxiety/depression that may be caused by unnecessary chest-x-rays or no chest x-rays
    Title
    Best measures of resource use to facilitate health economic analysis of the cost-effectiveness of 'extra-NICE'
    Title
    Stage at diagnosis, performance status, and the proportion of patients receiving radical treatments in those diagnosed with lung cancer
    Title
    False-positive and false-negative rates for chest x-rays

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    DISEASE CHARACTERISTICS: Patients over 60 seeing a participating General Practitioner Currently smokes 10 or more pack years, meeting at least one of the following criteria: New or altered cough of any duration reported to primary care Increased breathlessness or wheezing (with or without purulent sputum) Do not qualify for an urgent referral for a chest x-ray under the National Institute for Health and Clinical Excellence (NICE) guidelines (i.e., hemoptysis or unexplained or persistent [lasting > 3 weeks] signs or symptoms), including having any of the following: Cough Chest/shoulder pain Dyspnea Weight loss Chest signs Hoarseness Finger clubbing Features suggestive of metastasis from a lung cancer (e.g., in the brain, bone, liver, or skin) Cervical/supraclavicular lymphadenopathy PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: No chest x-ray within in past 3 months No need for a chest x-ray within the next 3 weeks for reasons other than those listed under Disease Characteristics
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Richard Neal, MD
    Organizational Affiliation
    North Wales Clinical School
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    35313926
    Citation
    Prout H, Tod A, Neal R, Nelson A. Maximising recruitment of research participants into a general practice based randomised controlled trial concerning lung diagnosis-staff insights from an embedded qualitative study. Trials. 2022 Mar 21;23(1):225. doi: 10.1186/s13063-022-06125-y.
    Results Reference
    derived
    PubMed Identifier
    30075741
    Citation
    Prout HC, Barham A, Bongard E, Tudor-Edwards R, Griffiths G, Hamilton W, Harrop E, Hood K, Hurt CN, Nelson R, Porter C, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Neal RD, Nelson A. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study. Trials. 2018 Aug 4;19(1):419. doi: 10.1186/s13063-018-2803-4.
    Results Reference
    derived
    PubMed Identifier
    28072761
    Citation
    Neal RD, Barham A, Bongard E, Edwards RT, Fitzgibbon J, Griffiths G, Hamilton W, Hood K, Nelson A, Parker D, Porter C, Prout H, Roberts K, Rogers T, Thomas-Jones E, Tod A, Yeo ST, Hurt CN. Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial. Br J Cancer. 2017 Jan;116(3):293-302. doi: 10.1038/bjc.2016.414. Epub 2017 Jan 10.
    Results Reference
    derived
    PubMed Identifier
    24279296
    Citation
    Hurt CN, Roberts K, Rogers TK, Griffiths GO, Hood K, Prout H, Nelson A, Fitzgibbon J, Barham A, Thomas-Jones E, Edwards RT, Yeo ST, Hamilton W, Tod A, Neal RD. A feasibility study examining the effect on lung cancer diagnosis of offering a chest X-ray to higher-risk patients with chest symptoms: protocol for a randomized controlled trial. Trials. 2013 Nov 26;14:405. doi: 10.1186/1745-6215-14-405.
    Results Reference
    derived

    Learn more about this trial

    Standard Medical Care or Urgent Chest X-ray in Diagnosing Lung Cancer in Smokers With Chest Symptoms Who Are Older Than 60 Years

    We'll reach out to this number within 24 hrs